Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patient Education Materials for Non-English Speakers

Katie Robinson  |  Issue: July 2023  |  July 10, 2023

Ms. French

Providing health education materials that are easy to understand is beneficial to both patients and clinicians. “Patients are able to understand their disease and participate more fully in their care, which leads to better health outcomes. Clear communication also helps build trust between patients and their doctors, increasing the opportunity to develop an open and productive relationship,” says Ms. French.

Health Literacy

According to the U.S. Department of Health and Human Services, only 12% of the U.S. population has proficient health literacy, meaning they have the skills to successfully navigate complex healthcare situations without difficulty.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Some of those most at risk of having low health literacy include people over 65, members of racial/ethnic minority groups and non-native English speakers. However, it’s impossible to know an individual’s health literacy level by their demographic information or even by whether they appear to understand,” Ms. French says.

The Lupus Foundation of America follows a universal precautions approach to health literacy. “Everyone learns differently, and we provide health education in a variety of formats so that everyone has the opportunity to receive information in the way that suits them best. All of our resources—articles, infographics, videos and podcasts—are created following health literacy best practices,” Ms. French says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Health literacy needs to be considered when speaking of rare and complex conditions, and cultural differences must be considered when creating educational resources. “The Vasculitis Foundation addressed this need by involving physicians from the region in the production of our video series,” Dr. Sattui says.

Dr. Ursani agrees that acknowledging health literacy is important, “which is why we maintain patient educational content at the sixth grade reading and comprehension level.”

The Future

Aside from the ACR producing patient educational materials in English and Spanish, “there is a push to expand to other commonly spoken languages, and we hope to accomplish this to expand the accessibility of our information in the future,” Dr. Ursani says.

In addition to creating and maintaining high-quality health education materials, the Lupus Foundation of America strives to engage people with lupus, their caregivers and their doctors. Take Charge is a 12-week email series that gives people with lupus information, strategies and resources to help them better understand and manage lupus. “This fall we will be launching a Spanish version, Tome Control, to better serve our Spanish-speaking constituents. We also take the opportunity to focus our outreach efforts through our Spotlight Series, which highlights resources for specific communities to raise awareness,” Ms. French says.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Patient PerspectivePractice Management Tagged with:health literacypatient education

Related Articles
    Hanna Kuprevich / shutterstock.com

    How to Help Your Patients Find Credible Information about Their Disease

    May 17, 2019

    Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

    Fall 2021’s Awards, Appointments & Announcements in Rheumatology

    October 13, 2021

    Jeffrey Siegel, MD, Assumes New Position as Director for New Office of Drug Evaluation Sciences at the FDA On Feb. 16, Jeffrey Siegel, MD, became the director of the recently created Office of Drug Evaluation Sciences at the U.S. Food & Drug Administration (FDA). The move, he says, “puts together many of the different things…

    How Rheumatologists Can Boost Patient Understanding of Educational Materials

    April 2, 2014

    Choosing appropriate, pre-written disease fact sheets, or writing your own educational documents can help patients with low health literacy comprehend information about their condition

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences